
The right treatment for the right ventricle
Author(s) -
Joanne A. Groeneveldt,
Frances S. de Man,
Berend E. Westerhof
Publication year - 2019
Publication title -
current opinion in pulmonary medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.937
H-Index - 75
eISSN - 1531-6971
pISSN - 1070-5287
DOI - 10.1097/mcp.0000000000000610
Subject(s) - medicine , afterload , preload , cardiology , ventricle , heart failure , contractility , pulmonary hypertension , intensive care medicine , hemodynamics
Right ventricular (RV) function is an important determinant of morbidity and mortality in patients with pulmonary arterial hypertension (PAH). Although substantial progress has been made in understanding the development of RV failure in the last decennia, this has not yet resulted in the development of RV selective therapies. In this review, we will discuss the current status on the treatment of RV failure and potential novel therapeutic strategies that are currently being investigated in clinical trials.